GO:1904356 regulation of telomere maintenance via telomere lengthening: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904356 describes any process that modulates the frequency, rate or extent of telomere maintenance via telomere lengthening, a biological_process ontology term.
• Telomere lengthening is carried out mainly by telomerase (TERT, TERC, DKC1) or by alternative lengthening of telomeres (ALT) mechanisms.
• Regulation occurs at multiple levels: TERT transcription, TERC processing, telomerase recruitment, and release from telomere ends.
• Dysregulation of this process is a hallmark of cancer, where telomere maintenance supports replicative immortality.
• Non-coding RNAs and RNA-binding proteins, such as ZC3H15 and NPM1, modulate telomerase trafficking and telomere elongation.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of regulators in this pathway.
Description
Telomeres are nucleoprotein structures that protect chromosome ends and shorten with each cell division. The process of telomere maintenance via telomere lengthening counteracts this shortening and is essential for stem cell function and cancer cell immortalization. GO:1904356, regulation of telomere maintenance via telomere lengthening, captures the regulatory inputs that control how, when, and where telomeres are extended. Understanding this term is critical because telomere lengthening is a central node in aging, cancer, and regenerative biology. This article synthesizes the QuickGO definition with published literature to provide a research-grade overview of the genes, mechanisms, and experimental models used to study GO:1904356.
regulation of telomere maintenance via telomere lengthening At A Glance
| GO ID | GO:1904356 |
|---|---|
| GO term | regulation of telomere maintenance via telomere lengthening |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of telomere lengthening |
| Related processes | Telomere maintenance, telomerase activity, ALT pathway |
| Key regulators | TERT, TERC, DKC1, NPM1, ZC3H15, microRNAs |
| Disease relevance | Cancer, aging, stem cell dysfunction |
What Is GO:1904356?
GO:1904356 is defined as any process that modulates the frequency, rate or extent of telomere maintenance via telomere lengthening. In other words, it encompasses all molecular and cellular events that regulate the addition of telomeric repeats to chromosome ends, whether through telomerase or alternative lengthening of telomeres (ALT).
Why Is regulation of telomere maintenance via telomere lengthening Important in Cell Biology?
Regulation of telomere maintenance via telomere lengthening is fundamental to genome stability and cellular lifespan. Its dysregulation is a hallmark of cancer, where telomerase reactivation or ALT enables unlimited proliferation. Conversely, insufficient telomere lengthening contributes to premature aging and stem cell exhaustion. Thus, understanding GO:1904356 provides mechanistic insight into both oncogenesis and degenerative diseases.
• Enables replicative immortality in cancer cells.
• Maintains stem cell pools and tissue regeneration.
• Prevents telomere shortening-associated aging phenotypes.
• Involved in alternative lengthening of telomeres (ALT) in some cancers.
• Regulated by microRNAs and RNA-binding proteins.
• Target for anti-cancer therapeutics.
• Affects telomerase trafficking and release.
• Modulated by phosphorylation events.
• Impacts neuromuscular and degenerative disorders.
• Provides biomarkers for pan-cancer analysis.
What Happens During regulation of telomere maintenance via telomere lengthening?
Telomerase Activation and Recruitment
In simple terms: The cell turns on and brings telomerase to chromosome ends.
Telomerase, composed of TERT and TERC, is the primary enzyme that elongates telomeres. Its regulation includes transcriptional control of TERT and recruitment to telomeres by accessory proteins such as DKC1 and NPM1. Phosphorylation of NPM1 stabilizes POLD3 and supports ALT-mediated telomere maintenance.
Alternative Lengthening of Telomeres (ALT)
In simple terms: Some cells use a backup method to lengthen telomeres without telomerase.
ALT is a homologous recombination-based mechanism that maintains telomeres in ~10-15% of cancers. NPM1 phosphorylation and POLD3 stabilization are involved in ALT-positive osteosarcoma. Pan-cancer analyses show ALT as a distinct telomere maintenance mechanism.
Telomerase Release and Homeostasis
In simple terms: After extending the telomere, telomerase must let go to keep length balanced.
Telomerase release from telomere ends is a regulated step that determines processivity and length homeostasis. Disruption of ZC3H15 traps telomerase in Cajal bodies, impairing telomere elongation.
MicroRNA-Dependent Regulation
In simple terms: Small RNAs can dial down telomere-lengthening proteins.
MicroRNAs regulate telomere maintenance mechanisms by targeting TERT and other components, representing an unexplored but promising field.
Key Genes Involved in GO:1904356 regulation of telomere maintenance via telomere lengthening
The following genes and proteins are central to the regulation of telomere maintenance via telomere lengthening.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERT | Catalytic subunit of telomerase | Target for cancer therapy |
| TERC | RNA template of telomerase | Mutations cause dyskeratosis congenita |
| DKC1 | Telomerase holoenzyme component | Links to ribosomopathies |
| NPM1 | Phosphorylation-mediated stabilization of POLD3 | ALT-positive osteosarcoma |
| ZC3H15 | Telomerase trafficking to Cajal bodies | Disruption impairs telomere length |
| POLD3 | DNA polymerase delta subunit | ALT telomere synthesis |
| TP53 | Tumor suppressor, regulates ALT | Pan-cancer telomere maintenance |
| MYC | Transcription factor for TERT | Oncogenic telomerase activation |
| SP1 | Transcription factor for TERT | Basal TERT expression |
| HIF1A | Hypoxia-induced TERT regulator | Cancer adaptation |
| NFKB1 | Inflammatory TERT regulator | Cancer inflammation |
| SMAD3 | TGF-beta signaling to TERT | Stem cell regulation |
| CTNNB1 | Wnt signaling to TERT | Stem cell and cancer |
| DICER1 | MicroRNA processing | MicroRNA-dependent telomere regulation |
| AGO2 | MicroRNA effector | MicroRNA-dependent telomere regulation |
| TERF1 | Telomere-binding protein | Shelterin complex |
| TERF2 | Telomere-binding protein | Shelterin complex |
How Is regulation of telomere maintenance via telomere lengthening Regulated?
Regulation of telomere maintenance via telomere lengthening is controlled at transcriptional, post-transcriptional, and post-translational levels. TERT transcription is driven by MYC, SP1, HIF1A, NFKB1, SMAD3, and CTNNB1. MicroRNAs fine-tune TERT and other components. Phosphorylation of NPM1 stabilizes POLD3 to support ALT. Telomerase release from telomeres is a regulated step for length homeostasis.
regulation of telomere maintenance via telomere lengthening and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TERT | Cancer, dyskeratosis congenita | Knockout and overexpression in cancer cell lines |
| NPM1 | ALT-positive osteosarcoma | Point mutation of phosphorylation sites |
| ZC3H15 | Telomere length maintenance defects | Knockout in HeLa cells |
| DKC1 | Dyskeratosis congenita | Knock-in of patient mutations |
| TERC | Dyskeratosis congenita | Knockout in stem cells |
Cancer
Telomere lengthening is a hallmark of cancer, enabling replicative immortality. TERT reactivation occurs in ~90% of cancers, while ALT operates in a subset. Targeting telomerase is a therapeutic strategy.
Neuromuscular Disorders
Muscle satellite cell dysfunction, linked to telomere maintenance defects, contributes to neuromuscular disorders.
Ribosomopathies and Dyskeratosis Congenita
Mutations in DKC1 and TERC cause dyskeratosis congenita, a premature aging syndrome with telomere shortening.
Osteosarcoma
NPM1 phosphorylation-mediated ALT via POLD3 stabilization is implicated in ALT-positive osteosarcoma.
From regulation of telomere maintenance via telomere lengthening-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TERT knockout reduce telomere length? | CRISPR knockout in cancer cell lines |
| Does NPM1 phosphorylation regulate ALT? | Point mutation of NPM1 phosphosites |
| Can ZC3H15 knockout impair telomerase trafficking? | Knockout in HeLa cells |
| Does TERC mutation cause telomere shortening? | Knock-in of patient mutations |
| Does TERT overexpression extend telomeres? | Overexpression in primary cells |
| Can microRNAs regulate TERT? | Overexpression of microRNA mimics |
How to Study the regulation of telomere maintenance via telomere lengthening Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TRF assay | Telomere length | Assessing telomere lengthening |
| Q-FISH | Telomere length at single-cell level | ALT detection |
| TRAP assay | Telomerase activity | TERT regulation |
| CRISPR screen | Gene essentiality for telomere maintenance | Identifying novel regulators |
| RNA-seq | Transcriptional changes | TERT and microRNA regulation |
| Proteomics | Protein interactions | Telomerase complex composition |
| ChIP-seq | TERT promoter binding | Transcription factor regulation |
| Immunofluorescence | Telomerase localization | Cajal body trafficking |
Telomere Length Measurement
Telomere restriction fragment (TRF) analysis and quantitative FISH (Q-FISH) measure telomere length to assess regulation of telomere maintenance.
Telomerase Activity Assays
TRAP assay detects telomerase activity, useful for evaluating TERT regulators.
CRISPR Screening
Genome-wide CRISPR screens identify regulators of telomere lengthening and ALT.
RNA-seq and Proteomics
RNA-seq and proteomics reveal expression changes in TERT, TERC, and associated factors.
How CRISPR Can Be Used to Study GO:1904356 regulation of telomere maintenance via telomere lengthening
Knockout
CRISPR knockout of TERT, ZC3H15, or NPM1 can abolish telomere lengthening and reduce telomere length, providing causal evidence.
Point Mutation
Point mutations in NPM1 phosphorylation sites or TERT promoter can dissect specific regulatory residues.
Knock-in
Knock-in of patient-derived TERC or DKC1 mutations models dyskeratosis congenita and telomere shortening.
Overexpression
Overexpression of TERT or microRNAs can extend telomeres and promote immortalization.
How EDITGENE Supports regulation of telomere maintenance via telomere lengthening Research
Researchers studying regulation of telomere maintenance via telomere lengthening-related genes often need to determine whether a candidate gene is causally involved in telomere elongation, ALT, or telomerase recruitment. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of telomere maintenance via telomere lengthening research.
Frequently Asked Questions About regulation of telomere maintenance via telomere lengthening
What is GO:1904356?
GO:1904356 is the Gene Ontology term for regulation of telomere maintenance via telomere lengthening, describing any process that modulates the frequency, rate or extent of telomere lengthening.
What genes are involved in regulation of telomere maintenance via telomere lengthening?
Key genes include TERT, TERC, DKC1, NPM1, ZC3H15, and POLD3, as well as microRNAs.
How is telomere lengthening regulated?
It is regulated at transcriptional, post-transcriptional, and post-translational levels, including TERT transcription, microRNA targeting, and phosphorylation of NPM1.
What is the difference between telomerase and ALT?
Telomerase uses TERT and TERC to add telomeric repeats, while ALT uses homologous recombination; both are regulated under GO:1904356.
Which diseases are linked to telomere lengthening dysregulation?
Cancer, dyskeratosis congenita, osteosarcoma, and neuromuscular disorders.
How can CRISPR help study telomere maintenance?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators.
What methods measure telomere length?
TRF assay, Q-FISH, and TRAP assay are commonly used.
Is NPM1 involved in telomere maintenance?
Yes, NPM1 phosphorylation stabilizes POLD3 and supports ALT in osteosarcoma.
What is the role of ZC3H15 in telomeres?
ZC3H15 disruption traps telomerase in Cajal bodies, impairing telomere length maintenance.
Can microRNAs regulate telomerase?
Yes, microRNAs can target TERT and other components, representing a promising research area.
Conclusion
GO:1904356, regulation of telomere maintenance via telomere lengthening, is a critical biological process with broad implications for cancer, aging, and stem cell biology. Understanding its regulators through CRISPR models and functional assays will advance therapeutic development.
References
- 1. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 2. Zhao R et al.. 2026. NPM1 phosphorylation-mediated telomere maintenance via stabilization of POLD3 in ALT-positive osteosarcoma: unraveling mechanisms and therapeutic opportunities.. Theranostics 16(8):4224-4244 PMID: 41695477
- 3. Guterres AN et al.. 2020. Targeting telomerase for cancer therapy.. Oncogene 39(36):5811-5824 PMID: 32733068
- 4. Santambrogio F et al.. 2014. MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising.. Curr Pharm Des 20(41):6404-21 PMID: 24975607
- 5. Wang C et al.. 2025. Disruption of ZC3H15 compromises telomere length maintenance by entrapping telomerase within cajal bodies.. Cell Biosci 15(1):107 PMID: 40696438
- 6. Dratwa M et al.. 2020. TERT-Regulation and Roles in Cancer Formation.. Front Immunol 11:589929 PMID: 33329574
- 7. Sung JY et al.. 2021. Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.. Int J Mol Sci 22(20) PMID: 34681758
- 8. Tomita K. 2018. How long does telomerase extend telomeres? Regulation of telomerase release and telomere length homeostasis.. Curr Genet 64(6):1177-1181 PMID: 29663033
